Medicines and Healthcare Products Regulatory Agency

The complainant has requested information about adverse reactions to approved COVID-19 vaccines. The Medicines and Healthcare Products Regulatory Agency (MHRA) is withholding the information under section 22(1) of the FOIA as it intends to publish it at some future date. The Commissioner’s decision is as follows: MHRA is entitled to withhold the requested information under section 22(1) of the FOIA and the public interest favours maintaining the exemption. MHRA’s refusal notice was inadequate and did not meet the requirements of section 17(3) of the FOIA. The Commissioner does not require MHRA to take any remedial steps. First-tier tribunal (General Regulatory chamber) information rights appeal EA/2022/0039 appeal dismissed.